BPC-157 & TB-500 40mg (R&D Only)

£129.00

BPC-157 & TB-500 40mg (R&D Only) is a popular choice for research-focused peptide and compound sourcing.
Premium-labelled quality with clear presentation and consistent sourcing.
In stock now with fast dispatch across UK.

Category: Alluvi Healthcare Tags: advanced peptide injection, bpc 157 peptide, bpc157, BPC157 & TB500, bpc157 injection, bpc157 peptide injection uk, bpc157 peptide pen, bpc157 research peptide, bpc157 tb500 blend, bpc157 tb500 blend pen, bpc157 tb500 injection pen, bpc157 tb500 pen, bpc157 tb500 stack, bpc157 tb500 uk, buy bpc157 tb500, laboratory peptide pen, muscle recovery peptide, peptide advanced recovery compound, peptide advanced therapy compound, peptide blend compound, peptide blend injection, peptide blend supplier uk, peptide blend therapy, peptide blend therapy pen, peptide blend uk, peptide compound blend, peptide compound injection, peptide connective tissue research, peptide healing research compound, peptide healing support injection, peptide injection compound uk, peptide injection pen, peptide injection research, peptide injection research blend, peptide injection supplier, peptide injection uk, peptide lab research injection, peptide lab tested compound, peptide muscle recovery injection, peptide muscle repair compound, peptide muscle support, peptide muscle support injection, peptide muscle therapy compound, peptide pen, peptide pen uk, peptide performance research, peptide performance support compound, peptide recovery blend, peptide recovery compound uk, peptide recovery injection, peptide recovery injection pen, peptide recovery therapy, peptide regeneration compound, peptide regeneration injection pen, peptide regeneration research, peptide regeneration therapy, peptide repair injection, peptide repair research compound, peptide research compound, peptide research compound uk, peptide research grade injection, peptide research injection, peptide research performance compound, peptide research product, peptide research solution, peptide research stack, peptide research supplier, peptide research therapy injection, peptide research therapy pen, peptide sports recovery compound, peptide sports therapy injection, peptide stack injection, peptide support injection, peptide support therapy, peptide therapy blend, peptide therapy blend injection, peptide therapy compound, peptide therapy injection, peptide therapy pen, peptide therapy supplier uk, peptide therapy uk, peptide tissue recovery, peptide tissue repair compound, recovery peptide pen, research peptide pen, research peptides uk, tb 500 peptide, tb500, tb500 injection, tb500 peptide injection uk, tb500 peptide pen, tb500 research peptide

Description

BPC-157 & TB-500 40mg (R&D Only)

Introduction to BPC-157 & TB-500 Research Peptides

BPC-157 & TB-500 40mg represents a dual-peptide research formulation designed for qualified laboratories conducting investigations into tissue repair mechanisms, cellular migration pathways, and angiogenesis. These synthetic peptides have gained attention in preclinical research for their distinct biological mechanisms and potential synergistic effects.

Manufactured under rigorously controlled conditions, our BPC-157 & TB-500 40mg combination is intended exclusively for laboratory research, analytical testing, and mechanistic studies—never for human or veterinary consumption.

Important Research Context

While these peptides have shown promising results in animal studies, it is critical to understand:

Human clinical data is extremely limited
Long-term safety profiles are unknown
Regulatory approval for therapeutic use does not exist
All evidence comes from preclinical laboratory models

Contact Wholesale Team

Product Specifications: BPC-157 & TB-500 40mg

Specification	BPC-157	TB-500
Chemical Name	Body Protection Compound-157	Thymosin Beta-4 Fragment
Amino Acid Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids)	Ac-LKKTETQ (7 amino acids, N-terminal acetylated)
Molecular Weight	~1,419 Da	~889 Da
Strength per Vial	20mg BPC-157	20mg TB-500
Total Combination	40mg total peptide content (20mg each)
Grade Classification	Research Use Only (RUO)
Form	Lyophilized peptide powder
Purity Level	≥98% each peptide (HPLC verified, COA provided per batch)
Intended Application	Laboratory & R&D use only – NOT for human or veterinary consumption
Storage Conditions	-20°C to -80°C (lyophilized form)

Each batch undergoes comprehensive quality control testing including HPLC purity verification, mass spectrometry identification, and sterility testing to ensure researchers receive materials that meet the highest industry standards.

Understanding BPC-157 & TB-500: Mechanisms and Origins

BPC-157: Gastric Pentadecapeptide

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protein found in human gastric juice. Originally isolated during research on gastric secretions, this pentadecapeptide has become a focal point in tissue repair research.

Proposed Mechanisms of Action

Research in animal models suggests BPC-157 operates through several interconnected pathways:

VEGF Receptor 2 (VEGFR2) Activation: Primary pathway for angiogenesis and new blood vessel formation
Growth Hormone Receptor Upregulation: Dose-dependent increases in tendon fibroblast growth hormone receptor expression
Focal Adhesion Kinase (FAK)-Paxillin Pathway: Facilitates cell migration and attachment to surfaces during wound healing
JAK-2 Signaling: Relays signals for cell survival, growth, and immune responses
Early Growth Response Gene 1 (Egr-1): Acts as a master switch for genes involved in cell growth and blood vessel formation
ERK1/2 Pathway: Involved in cellular proliferation and differentiation
Nitric Oxide (NO) Modulation: Regulates vascular function and inflammatory responses

Critical Research Limitations

Despite promising preclinical findings, researchers must note:

Almost all studies are limited to rodent models (rats and mice)
No completed Phase III clinical trials exist
The mechanism of action is not fully understood
Human pharmacokinetics are largely unknown
Potential adverse effects in humans remain unstudied

TB-500: Thymosin Beta-4 Fragment

TB-500 is a synthetic 7-amino-acid fragment (Ac-LKKTETQ) corresponding to the actin-binding region of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found in nearly all human cells. First isolated from thymus tissue, thymosin beta-4 plays fundamental roles in cytoskeletal organization.

Proposed Mechanisms of Action

Laboratory research indicates TB-500 functions primarily through:

G-Actin Sequestration: Binds monomeric actin, preventing premature polymerization and maintaining actin pools for rapid cytoskeletal reorganization
Enhanced Cellular Migration: Facilitates cell movement essential for wound healing and tissue repair
Angiogenesis Promotion: Upregulates VEGF expression and enhances endothelial cell sprouting
Anti-inflammatory Effects: Reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)
ILK-Akt Pathway Activation: Supports cell survival and inhibits apoptosis
Collagen Organization: Influences extracellular matrix remodeling

TB-500 vs. Full-Length Thymosin Beta-4

Important distinctions for researchers:

TB-500 contains only the actin-binding motif (7 amino acids)
Full thymosin beta-4 is 43 amino acids with additional functional domains
TB-500 is a targeted probe for actin-related behavior only
Full Tβ4 may have broader biological effects not replicated by TB-500
Research findings may not be directly comparable between the two forms

Research Applications for BPC-157 & TB-500

Individual Peptide Research Areas

BPC-157 Research Applications

Tendon and ligament injury models in rodents
Muscle detachment and healing studies
Gastric mucosal protection research
Vascular occlusion syndrome models
Bone healing and fracture recovery studies
Neuromuscular junction stabilization research
VEGFR2 signaling pathway investigations
Growth hormone receptor expression studies

TB-500 Research Applications

Actin polymerization and cytoskeletal dynamics
Cell migration assays and wound healing models
Corneal wound healing research
Dermal wound closure studies
Cardiac tissue repair models post-ischemia
Angiogenesis pathway investigations
Anti-inflammatory mechanism studies
Fibroblast activity and collagen synthesis research

Combined Research Investigations

Researchers have explored combining BPC-157 and TB-500 based on their complementary mechanisms:

Synergistic Pathway Analysis: Investigating how VEGF-mediated angiogenesis (both peptides) combines with unique mechanisms
Comparative Efficacy Studies: Evaluating single vs. combination peptide effects in tissue repair models
Multi-Modal Tissue Repair: Examining combined effects on fibroblast activity, collagen synthesis, and vascular regeneration
Dose-Response Optimization: Determining optimal ratios and concentrations for laboratory studies

Publication Bias Alert

Researchers should be aware that published studies on BPC-157 and TB-500 show a strong positive bias. Nearly all published research reports beneficial effects, suggesting possible:

Selective publication of positive results
Insufficient reporting of failed experiments
Limited reproducibility data from independent laboratories
Potential conflicts of interest in some research groups

Bulk Supply & Wholesale Program for Research Institutions

The BPC-157 & TB-500 40mg formulation is available through our specialized bulk supply program, designed exclusively for qualified research organizations with appropriate credentials and oversight.

Qualified Buyer Categories

Academic research laboratories and university research centers
Pharmaceutical R&D facilities conducting preclinical studies
Biotechnology companies with peptide research programs
Contract research organizations (CROs) specializing in tissue repair mechanisms
Quality control and analytical testing laboratories

Sign up for Newsletter

BPC-157 & TB-500 40mg (R&D Only)

BPC-157 & TB-500 40mg (R&D Only)